- Home
- NCL vs PAVM Comparison
NCL vs PAVM Comparison
Compare NCL & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCL
- PAVM
- Stock Information
- Founded
- NCL 2013
- PAVM 2014
- Country
- NCL United States
- PAVM United States
- Employees
- NCL N/A
- PAVM N/A
- Industry
- NCL
- PAVM Medical/Dental Instruments
- Sector
- NCL
- PAVM Health Care
- Exchange
- NCL Nasdaq
- PAVM Nasdaq
- Market Cap
- NCL 12.2M
- PAVM 10.5M
- IPO Year
- NCL 2023
- PAVM 2016
- Fundamental
- Price
- NCL $0.20
- PAVM $0.60
- Analyst Decision
- NCL
- PAVM Strong Buy
- Analyst Count
- NCL 0
- PAVM 1
- Target Price
- NCL N/A
- PAVM $19.00
- AVG Volume (30 Days)
- NCL 145.4K
- PAVM 150.9K
- Earning Date
- NCL 05-19-2025
- PAVM 05-12-2025
- Dividend Yield
- NCL N/A
- PAVM N/A
- EPS Growth
- NCL N/A
- PAVM N/A
- EPS
- NCL N/A
- PAVM 0.50
- Revenue
- NCL $15,576,857.00
- PAVM $2,995,000.00
- Revenue This Year
- NCL N/A
- PAVM N/A
- Revenue Next Year
- NCL N/A
- PAVM $239.89
- P/E Ratio
- NCL N/A
- PAVM $1.20
- Revenue Growth
- NCL 47.13
- PAVM 22.14
- 52 Week Low
- NCL $0.15
- PAVM $0.57
- 52 Week High
- NCL $0.69
- PAVM $2.43
- Technical
- Relative Strength Index (RSI)
- NCL 42.49
- PAVM 35.84
- Support Level
- NCL $0.19
- PAVM $0.74
- Resistance Level
- NCL $0.22
- PAVM $0.84
- Average True Range (ATR)
- NCL 0.02
- PAVM 0.06
- MACD
- NCL 0.00
- PAVM -0.02
- Stochastic Oscillator
- NCL 18.75
- PAVM 2.02
About NCL Northann Corp.
Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. Northann offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, primarily through its sales network in North America and Europe.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.